These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32403446)

  • 1. Contemporary Cardiovascular Risk Assessment for Type 2 Diabetes Including Heart Failure as an Outcome: The Fremantle Diabetes Study Phase II.
    Davis WA; Hellbusch V; Hunter ML; Bruce DG; Davis TME
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32403446
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse cardiovascular outcomes in atrial fibrillation: Validation of the new 2MACE risk score.
    Polovina M; Đikić D; Vlajković A; Vilotijević M; Milinković I; Ašanin M; Ostojić M; Coats AJS; Seferović PM
    Int J Cardiol; 2017 Dec; 249():191-197. PubMed ID: 28986061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
    Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
    Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinopathy predicts stroke but not myocardial infarction in type 2 diabetes: the Fremantle Diabetes Study Phase II.
    Drinkwater JJ; Davis TME; Hellbusch V; Turner AW; Bruce DG; Davis WA
    Cardiovasc Diabetol; 2020 Mar; 19(1):43. PubMed ID: 32234054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Performance of the RECODe Equation with the Addition of Polygenic Risk Scores for Adverse Cardiovascular Outcomes in Individuals with Type II Diabetes.
    Tsao NL; Judy R; Levin MG; Shakt G; ; ; Voight BF; Chen J; Damrauer SM
    medRxiv; 2023 May; ():. PubMed ID: 37205500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a risk score for patients with ischaemic cardiomyopathy.
    Ródenas-Alesina E; Romero-Farina G; Herrador L; Jordán P; Espinet-Coll C; Pizzi MN; Ribera A; Ferreira-González I; Aguadé-Bruix S
    Arch Cardiovasc Dis; 2023 Mar; 116(3):145-150. PubMed ID: 36759315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent predictors of major adverse cardiovascular events in emergency department patients who are hospitalised with a suspected infection: a retrospective cohort study.
    de Groot B; van den Berg S; Kessler J; Ansems A; Rijpsma D
    BMJ Open; 2016 Jan; 6(1):e009598. PubMed ID: 26817637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External validation of a cardiovascular risk model for Omani patients with type 2 diabetes mellitus: a retrospective cohort study.
    Al Oraimi F; Al Rawahi A; Al Harrasi A; Albusafi S; Al-Manji LM; Alrawahi AH; Al Salmani AA
    BMJ Open; 2023 Nov; 13(11):e071369. PubMed ID: 37968004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observed versus predicted cardiovascular events and all-cause death in HIV infection: a longitudinal cohort study.
    De Socio GV; Pucci G; Baldelli F; Schillaci G
    BMC Infect Dis; 2017 Jun; 17(1):414. PubMed ID: 28606059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data.
    Young JB; Gauthier-Loiselle M; Bailey RA; Manceur AM; Lefebvre P; Greenberg M; Lafeuille MH; Duh MS; Bookhart B; Wysham CH
    Cardiovasc Diabetol; 2018 Aug; 17(1):118. PubMed ID: 30143045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cardiovascular risk calculator for renal transplant recipients.
    Soveri I; Holme I; Holdaas H; Budde K; Jardine AG; Fellström B
    Transplantation; 2012 Jul; 94(1):57-62. PubMed ID: 22683851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MELD-Na score predicts incident major cardiovascular events, in patients with nonalcoholic fatty liver disease (NAFLD).
    Simon TG; Kartoun U; Zheng H; Chan AT; Chung RT; Shaw S; Corey KE
    Hepatol Commun; 2017 Jul; 1(5):429-438. PubMed ID: 29085919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events: A Post Hoc Analysis of a Randomized Clinical Trial.
    Verma S; Bain SC; Buse JB; Idorn T; Rasmussen S; Ørsted DD; Nauck MA
    JAMA Cardiol; 2019 Dec; 4(12):1214-1220. PubMed ID: 31721979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials.
    Ghosh-Swaby OR; Goodman SG; Leiter LA; Cheng A; Connelly KA; Fitchett D; Jüni P; Farkouh ME; Udell JA
    Lancet Diabetes Endocrinol; 2020 May; 8(5):418-435. PubMed ID: 32333878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Combined CT Angiography and Myocardial Perfusion Imaging versus Invasive Coronary Angiography and Nuclear Stress Perfusion Imaging in the Prediction of Major Adverse Cardiovascular Events: The CORE320 Multicenter Study.
    Chen MY; Rochitte CE; Arbab-Zadeh A; Dewey M; George RT; Miller JM; Niinuma H; Yoshioka K; Kitagawa K; Sakuma H; Laham R; Vavere AL; Cerci RJ; Mehra VC; Nomura C; Kofoed KF; Jinzaki M; Kuribayashi S; Scholte AJ; Laule M; Tan SY; Hoe J; Paul N; Rybicki FJ; Brinker JA; Arai AE; Matheson MB; Cox C; Clouse ME; Di Carli MF; Lima JAC
    Radiology; 2017 Jul; 284(1):55-65. PubMed ID: 28290782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil-to-lymphocyte ratio predicts heart failure readmissions and outcomes in patients undergoing transcatheter aortic valve replacement.
    Khalil C; Pham M; Sawant AC; Sinibaldi E; Bhardwaj A; Ramanan T; Qureshi R; Khan S; Ibrahim A; Gowda SN; Pomakov A; Sadawarte P; Lahoti A; Hansen R; Baldo S; Colern G; Pershad A; Iyer V
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S313-S318. PubMed ID: 30595282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular event costs in patients with Type 2 diabetes mellitus.
    Johnston SS; Sheehan JJ; Shah M; Cappell K; Princic N; Smith D; Kalsekar I
    J Med Econ; 2015; 18(12):1032-40. PubMed ID: 26189723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk prediction in healthy older people.
    Neumann JT; Thao LTP; Callander E; Chowdhury E; Williamson JD; Nelson MR; Donnan G; Woods RL; Reid CM; Poppe KK; Jackson R; Tonkin AM; McNeil JJ
    Geroscience; 2022 Feb; 44(1):403-413. PubMed ID: 34762275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase I.
    Davis WA; Hamilton EJ; Bruce DG; Davis TME
    Diabetes Care; 2019 Jan; 42(1):102-109. PubMed ID: 30455327
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.